Edwards Lifesciences Corp (EW)vsENvue Medical Inc. (FEED)
EW
Edwards Lifesciences Corp
$94.37
-1.70%
HEALTHCARE · Cap: $51.66B
FEED
ENvue Medical Inc.
$0.52
+2.24%
HEALTHCARE · Cap: $3.14M
Smart Verdict
WallStSmart Research — data-driven comparison
Edwards Lifesciences Corp generates 288919% more annual revenue ($6.30B vs $2.18M). EW leads profitability with a 17.4% profit margin vs 0.0%. EW earns a higher WallStSmart Score of 59/100 (C).
EW
Buy59
out of 100
Grade: C
FEED
Avoid30
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+68.5%
Fair Value
$251.46
Current Price
$94.37
$157.09 discount
Intrinsic value data unavailable for FEED.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 31.2%
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Large-cap with strong market position
16.7% revenue growth
Reasonable price relative to book value
Conservative balance sheet, low leverage
Areas to Watch
Expensive relative to growth rate
Weak financial health signals
Premium valuation, high expectations priced in
Negative free cash flow — burning cash
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : EW
The strongest argument for EW centers on Operating Margin, Debt/Equity, Altman Z-Score. Profitability is solid with margins at 17.4% and operating margin at 31.2%. Revenue growth of 16.7% demonstrates continued momentum.
Bull Case : FEED
The strongest argument for FEED centers on Price/Book, Debt/Equity.
Bear Case : EW
The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 48.5x leaves little room for execution misses.
Bear Case : FEED
The primary concerns for FEED are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
EW profiles as a growth stock while FEED is a value play — different risk/reward profiles.
FEED carries more volatility with a beta of 1.50 — expect wider price swings.
EW is growing revenue faster at 16.7% — sustainability is the question.
FEED generates stronger free cash flow (-4M), providing more financial flexibility.
Bottom Line
EW scores higher overall (59/100 vs 30/100), backed by strong 17.4% margins and 16.7% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Edwards Lifesciences Corp
HEALTHCARE · MEDICAL DEVICES · USA
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Visit Website →ENvue Medical Inc.
HEALTHCARE · MEDICAL DEVICES · USA
ENvue Medical Inc. (FEED) is an innovative healthcare technology company dedicated to enhancing patient care management through cutting-edge medical devices and integrated software solutions. By leveraging advanced technology, ENvue aims to streamline recovery processes and optimize health outcomes across diverse clinical environments. With a strong pipeline of products and strategic partnerships, the company is well-equipped to capitalize on the expanding opportunities in the healthcare sector, making it an attractive investment prospect for institutional investors interested in the evolution of medical devices and digital health innovations.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?